1. Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report. (20th July 2017) Authors: Sobas, M. A.; Wróbel, T.; Zduniak, K.; Podolak-Dawidziak, M.; Rybka, J.; Biedroń, M.; Sawicki, M.; Dybko, J.; Kuliczkowski, K. Other Names: Arellano-Rodrigo Eduardo Academic Editor. Journal: Case reports in hematology Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. (23rd June 2022) Authors: Zaleska, J.; Kwaśnik, P.; Paziewska, M.; Purkot, J.; Szabelak, A.; Jurek, M.; Masny, N.; Dziatkiewicz, I.; Własiuk, P.; Skórka, K.; Stasiak, G.; Pronobis-Szczylik, B.; Piebiak, A.; Szymczyk, A.; Jarosz-Chudzik, K.; Bołkun, L.; Kozłowska, K.; Piszcz, J.; Subocz, E.; Hałka, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P435: ANALYSIS OF MYELOBLAST IMMUNOPHENOTYPE PROFILE IN ACUTE MYELOID LEUKAEMIA AS PREDICTOR FOR CLINICAL OUTCOME. (23rd June 2022) Authors: Sobas, M.; Nowak, M.; Szymczak, D.; Andrasiak, I.; Wróbel, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P632: ORAL AND GUT MICROBIAL DIVERSITY CORRELATES WITH PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Szelest, M.; Paziewska, M.; Kiełbus, M.; Masternak, M.; Zaleska, J.; Wawrzyniak, E.; Kalicińska, E.; Jabłonowska, P.; Wróbel, T.; Wolska-Washer, A.; Błoński, J. Z.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM-CELL TRANSPLANT FOR MULTIPLE MYELOMA. (23rd June 2022) Authors: Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Kubicki, T.; Robak, P.; Walter-Croneck, A.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; Szczepaniak, T.; Łojko-Dankowska, A.; Matuszak, M.; Gil, L.; Puła, B.; Rybka, J.; Majcherek, M.; Usnarska-Zubkiewicz, L.; Szukalski, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S220: GLOFITAMAB INDUCES DURABLE COMPLETE REMISSIONS AND HAS FAVORABLE SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND ≥2 PRIOR THERAPIES: PIVOTAL PHASE II EXPANSION RESULTS. (23rd June 2022) Authors: Dickinson, M.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Corradini, P.; Iacoboni, G.; Khan, C.; Wróbel, T.; Offner, F.; Trněný, M.; Wu, S.-J.; Cartron, G.; Hertzberg, M.; Sureda, A.; Perez-Callejo, D.; Lundberg, L.; Relf, J.; Clark, E.; Humphrey, K.; Hutchings, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Variations in genes involved in regulation of the nuclear factor – κB pathway and the risk of acute myeloid leukaemia. (25th February 2016) Authors: Rybka, J.; Gębura, K.; Wróbel, T.; Wysoczańska, B.; Stefanko, E.; Kuliczkowski, K.; Bogunia‐Kubik, K. Journal: International journal of immunogenetics Issue: Volume 43:Number 2(2016:Apr.) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗